Labcorp partners with AWS, Datavant on AI real-world data platform for Alzheimer’s research
PUBT · 04/14 11:05
Share
Listen to the news
- Labcorp launched an AI-powered real-world data platform with Amazon Web Services, aiming to speed analysis of Alzheimer’s disease datasets for drug development.
- Datavant provides privacy-preserving connectivity to support secure use of deidentified healthcare data across the platform.
- Platform targets insight generation in minutes versus months, aiming to shorten drug development timelines.
- Initial validation is slated for spring 2026.
- Expansion is expected through 2026 to add more data sources, extending analytics beyond Alzheimer’s into other disease areas.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Labcorp Holdings Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202604140700PR_NEWS_USPR_____DC33531) on April 14, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2026 Webull. All Rights Reserved